Back to results
US 2013/0259832 A1Published application
Combinations of Hepatitis C Virus Inhibitors
OwnerJulie A. Lemm, Stacey A. Voss +4inventors
InventorsJulie A. Lemm, Stacey A. Voss, Min Gao, Susan E. Chaniewski, Amy K. Sheaffer, Fiona McPhee
Life of this patent
Estimating the term…
Abstract
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating Hepatitis C using such combinations.
Claims8
A composition comprising a therapeutically effective amount of a compound of formula (I)
- or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of a compound of formula (II),
- or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.